GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
GlycoMimetics (GLYC) - P/B ratio
P/B ratio as of April 2024 : 2.26
According to GlycoMimetics
's latest financial reports the company has a price-to-book ratio of 2.26.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
GlycoMimetics - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.26 | -11.76% |
| 2022-12-31 | 3.70 | 305.27% |
| 2021-12-31 | 0.9130 | -36.48% |
| 2020-12-31 | 1.44 | -3.6% |
| 2019-12-31 | 1.49 | -25.04% |
| 2018-12-31 | 1.99 | -58.7% |
| 2017-12-31 | 4.82 | 20.84% |
| 2016-12-31 | 3.99 | 48.03% |
| 2015-12-31 | 2.69 | 0.31% |
| 2014-12-31 | 2.68 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.12 | 126.32% | 🇺🇸 USA |
 Pfizer PFE | 1.61 | -28.83% | 🇺🇸 USA |
 Sanofi SNY | 1.49 | -33.95% | 🇫🇷 France |
 Palatin Technologies PTN | -2.57 | -213.71% | 🇺🇸 USA |
 bluebird bio
BLUE | 0.8012 | -64.59% | 🇺🇸 USA |